The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs

Bibliographic Details
Main Authors: Phillips Patrick PJ, Crook Angela, Nunn Andrew J
Format: Article
Language:English
Published: BMC 2011-12-01
Series:Trials
id doaj-8e14474a24d344978229e37b87f06472
record_format Article
spelling doaj-8e14474a24d344978229e37b87f064722020-11-25T00:01:32ZengBMCTrials1745-62152011-12-0112Suppl 1A3110.1186/1745-6215-12-S1-A31The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designsPhillips Patrick PJCrook AngelaNunn Andrew J
collection DOAJ
language English
format Article
sources DOAJ
author Phillips Patrick PJ
Crook Angela
Nunn Andrew J
spellingShingle Phillips Patrick PJ
Crook Angela
Nunn Andrew J
The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs
Trials
author_facet Phillips Patrick PJ
Crook Angela
Nunn Andrew J
author_sort Phillips Patrick PJ
title The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs
title_short The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs
title_full The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs
title_fullStr The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs
title_full_unstemmed The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs
title_sort evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs
publisher BMC
series Trials
issn 1745-6215
publishDate 2011-12-01
work_keys_str_mv AT phillipspatrickpj theevolutionofandchallengesindefiningtheclinicalendpointintuberculosistreatmenttrialswithnoninferioritydesigns
AT crookangela theevolutionofandchallengesindefiningtheclinicalendpointintuberculosistreatmenttrialswithnoninferioritydesigns
AT nunnandrewj theevolutionofandchallengesindefiningtheclinicalendpointintuberculosistreatmenttrialswithnoninferioritydesigns
AT phillipspatrickpj evolutionofandchallengesindefiningtheclinicalendpointintuberculosistreatmenttrialswithnoninferioritydesigns
AT crookangela evolutionofandchallengesindefiningtheclinicalendpointintuberculosistreatmenttrialswithnoninferioritydesigns
AT nunnandrewj evolutionofandchallengesindefiningtheclinicalendpointintuberculosistreatmenttrialswithnoninferioritydesigns
_version_ 1725441569655357440